Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

The Active Tumor Vaccination in Combination With CDK4/6 Inhibitor Treatment: A Case Report

OFRA MAIMON, BENJAMIN NISMAN, SHANI BROIER, INNA BEN-DAVID, ANNA KUZNETZ, YAEL GELFAND, AVITAL MIZRAHI, EUGENIA PRUS, INBAL FUCHS, MICHAL LOTEM, ARON POPOVTZER, SALOME KHUTSURAULI, AMICHAY MEIROVITZ, HOVAV NECHUSHTAN and TAMAR PERETZ
Anticancer Research August 2024, 44 (8) 3543-3550; DOI: https://doi.org/10.21873/anticanres.17175
OFRA MAIMON
1Department of Oncology, Hadassah and Hebrew University Medical Centre, Jerusalem, Israel;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
BENJAMIN NISMAN
1Department of Oncology, Hadassah and Hebrew University Medical Centre, Jerusalem, Israel;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: bnisman{at}gmail.com
SHANI BROIER
1Department of Oncology, Hadassah and Hebrew University Medical Centre, Jerusalem, Israel;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
INNA BEN-DAVID
1Department of Oncology, Hadassah and Hebrew University Medical Centre, Jerusalem, Israel;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ANNA KUZNETZ
1Department of Oncology, Hadassah and Hebrew University Medical Centre, Jerusalem, Israel;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YAEL GELFAND
1Department of Oncology, Hadassah and Hebrew University Medical Centre, Jerusalem, Israel;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
AVITAL MIZRAHI
1Department of Oncology, Hadassah and Hebrew University Medical Centre, Jerusalem, Israel;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
EUGENIA PRUS
2Department of Hematology, Hadassah and Hebrew University Medical Centre, Jerusalem, Israel;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
INBAL FUCHS
1Department of Oncology, Hadassah and Hebrew University Medical Centre, Jerusalem, Israel;
3Faculty of Medicine, Hebrew University, Jerusalem, Israel;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MICHAL LOTEM
1Department of Oncology, Hadassah and Hebrew University Medical Centre, Jerusalem, Israel;
3Faculty of Medicine, Hebrew University, Jerusalem, Israel;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ARON POPOVTZER
1Department of Oncology, Hadassah and Hebrew University Medical Centre, Jerusalem, Israel;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SALOME KHUTSURAULI
1Department of Oncology, Hadassah and Hebrew University Medical Centre, Jerusalem, Israel;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
AMICHAY MEIROVITZ
4The Legacy Heritage Oncology Center, Soroka University Medical Center, Beer-Sheva, Israel;
5Faculty of Medicine, Ben Gurion University of the Negev, Beer-Sheva, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HOVAV NECHUSHTAN
1Department of Oncology, Hadassah and Hebrew University Medical Centre, Jerusalem, Israel;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TAMAR PERETZ
1Department of Oncology, Hadassah and Hebrew University Medical Centre, Jerusalem, Israel;
3Faculty of Medicine, Hebrew University, Jerusalem, Israel;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 44 no. 8 3543-3550
DOI 
https://doi.org/10.21873/anticanres.17175
PubMed 
39060086

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received April 13, 2024
  • Revision received May 30, 2024
  • Accepted June 13, 2024
  • Published online July 26, 2024.

Copyright & Usage 
Copyright © 2024 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Author Information

  1. OFRA MAIMON1,*,
  2. BENJAMIN NISMAN1⇑*,
  3. SHANI BROIER1,
  4. INNA BEN-DAVID1,
  5. ANNA KUZNETZ1,
  6. YAEL GELFAND1,
  7. AVITAL MIZRAHI1,
  8. EUGENIA PRUS2,
  9. INBAL FUCHS1,3,
  10. MICHAL LOTEM1,3,
  11. ARON POPOVTZER1,
  12. SALOME KHUTSURAULI1,
  13. AMICHAY MEIROVITZ4,5,
  14. HOVAV NECHUSHTAN1 and
  15. TAMAR PERETZ1,3
  1. 1Department of Oncology, Hadassah and Hebrew University Medical Centre, Jerusalem, Israel;
  2. 2Department of Hematology, Hadassah and Hebrew University Medical Centre, Jerusalem, Israel;
  3. 3Faculty of Medicine, Hebrew University, Jerusalem, Israel;
  4. 4The Legacy Heritage Oncology Center, Soroka University Medical Center, Beer-Sheva, Israel;
  5. 5Faculty of Medicine, Ben Gurion University of the Negev, Beer-Sheva, Israel
  1. Correspondence to: Benjamin Nisman, Department of Oncology, Hadassah and Hebrew University Medical Centre, P.O. Box 12000, Jerusalem 91120, Israel. Tel: +972 508946713, e-mail: bnisman{at}gmail.com
  1. ↵* These Authors contributed equally to the present study.

View Full Text

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In this issue

Anticancer Research: 44 (8)
Anticancer Research
Vol. 44, Issue 8
August 2024
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The Active Tumor Vaccination in Combination With CDK4/6 Inhibitor Treatment: A Case Report
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
6 + 12 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
The Active Tumor Vaccination in Combination With CDK4/6 Inhibitor Treatment: A Case Report
OFRA MAIMON, BENJAMIN NISMAN, SHANI BROIER, INNA BEN-DAVID, ANNA KUZNETZ, YAEL GELFAND, AVITAL MIZRAHI, EUGENIA PRUS, INBAL FUCHS, MICHAL LOTEM, ARON POPOVTZER, SALOME KHUTSURAULI, AMICHAY MEIROVITZ, HOVAV NECHUSHTAN, TAMAR PERETZ
Anticancer Research Aug 2024, 44 (8) 3543-3550; DOI: 10.21873/anticanres.17175

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
The Active Tumor Vaccination in Combination With CDK4/6 Inhibitor Treatment: A Case Report
OFRA MAIMON, BENJAMIN NISMAN, SHANI BROIER, INNA BEN-DAVID, ANNA KUZNETZ, YAEL GELFAND, AVITAL MIZRAHI, EUGENIA PRUS, INBAL FUCHS, MICHAL LOTEM, ARON POPOVTZER, SALOME KHUTSURAULI, AMICHAY MEIROVITZ, HOVAV NECHUSHTAN, TAMAR PERETZ
Anticancer Research Aug 2024, 44 (8) 3543-3550; DOI: 10.21873/anticanres.17175
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Case Report
    • Discussion
    • Conclusion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Efficacy of SGLT-2 Inhibitors in Preventing Cisplatin-induced Kidney Injury in Patients With Diabetes
  • Association of Tumor Budding Grade With Immunohistochemical Expression of Thrombin and PAR-1 in Pancreatic Ductal Adenocarcinoma
  • Laparoscopy-assisted Partial Cecum Resection Versus Ileocecal Resection for Non-malignant Appendiceal Neoplasms
Show more Clinical Studies

Similar Articles

Keywords

  • Metastatic breast cancer
  • CDK4/6 inhibitors
  • cancer vaccination
  • COVID-19 vaccination
  • cytokines
  • thymidine kinase 1
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire